Inspire Medical Systems Total Current Liabilities 2017-2025 | INSP

Inspire Medical Systems total current liabilities from 2017 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Inspire Medical Systems Annual Total Current Liabilities
(Millions of US $)
2024 $89
2023 $78
2022 $61
2021 $41
2020 $21
2019 $17
2018 $11
2017 $7
2016 $0
Inspire Medical Systems Quarterly Total Current Liabilities
(Millions of US $)
2025-03-31 $63
2024-12-31 $89
2024-09-30 $74
2024-06-30 $66
2024-03-31 $72
2023-12-31 $78
2023-09-30 $70
2023-06-30 $67
2023-03-31 $60
2022-12-31 $61
2022-09-30 $49
2022-06-30 $47
2022-03-31 $43
2021-12-31 $41
2021-09-30 $34
2021-06-30 $24
2021-03-31 $19
2020-12-31 $21
2020-09-30 $18
2020-06-30 $13
2020-03-31 $14
2019-12-31 $17
2019-09-30 $13
2019-06-30 $9
2019-03-31 $8
2018-12-31 $11
2018-09-30 $8
2018-06-30 $9
2018-03-31 $8
2017-12-31 $7
2017-09-30
2017-06-30
2017-03-31
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.222B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.731B 53.50
Hims & Hers Health (HIMS) United States $11.944B 124.09
Tempus AI (TEM) United States $11.403B 0.00
IRhythm Technologies (IRTC) United States $4.673B 0.00
Privia Health (PRVA) United States $2.843B 194.33
Enovis (ENOV) United States $1.910B 10.65
Clover Health Investments (CLOV) United States $1.634B 0.00
Schrodinger (SDGR) United States $1.578B 0.00
Phreesia (PHR) United States $1.484B 0.00
Omnicell (OMCL) United States $1.387B 24.47
Azenta (AZTA) United States $1.269B 58.98
10x Genomics (TXG) United States $1.058B 0.00
Butterfly Network (BFLY) United States $0.626B 0.00
Fulgent Genetics (FLGT) United States $0.615B 0.00
Talkspace (TALK) United States $0.494B 147.50
Veradigm (MDRX) United States $0.460B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.391B 0.00
TruBridge (TBRG) United States $0.361B 801.00
Outset Medical (OM) United States $0.333B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
KORU Medical Systems (KRMD) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.134B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.087B 3.32
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00